AKT1 and plasma cell myeloma: In the context of the regulatory relationship between ROR2 and Akt, studies have indicated that ROR2 can modulate Akt phosphorylation through activation or inhibition in different cancers, including melanoma, breast cancer, myeloma, and osteosarcoma [41–44].